Table of Content
Table of Content
1 Oncology Molecular Diagnostics Introduction and Market Overview
1.1 Objectives of the Study
1.2 Overview of Oncology Molecular Diagnostics
1.3 Oncology Molecular Diagnostics Market Scope and Market Size Estimation
1.3.1 Market Concentration Ratio and Market Maturity Analysis
1.3.2 Global Oncology Molecular Diagnostics Revenue and Growth Rate from 2018-2030
1.4 Market Segmentation
1.4.1 Types of Oncology Molecular Diagnostics
1.4.2 Applications of Oncology Molecular Diagnostics
1.4.3 Research Regions
1.5 Market Dynamics
1.5.1 Oncology Molecular Diagnostics Industry Trends
1.5.2 Oncology Molecular Diagnostics Drivers
1.5.3 Oncology Molecular Diagnostics Market Challenges
1.5.4 Oncology Molecular Diagnostics Market Restraints
1.6 Industry News and Policies by Regions
1.6.1 Industry News
1.6.2 Industry Policies
1.7 Mergers & Acquisitions, Expansion Plans
1.8 Oncology Molecular Diagnostics Industry Development Trends under COVID-19 Outbreak
1.8.1 Global COVID-19 Status Overview
1.8.2 Influence of COVID-19 Outbreak on Oncology Molecular Diagnostics Industry Development
2 Industry Chain Analysis
2.1 Upstream Raw Material Supply and Demand Analysis
2.1.1 Global Oncology Molecular Diagnostics Major Upstream Raw Material and Suppliers
2.1.2 Raw Material Source Analysis
2.2 Major Players of Oncology Molecular Diagnostics
2.2.1 Major Players Manufacturing Base of Oncology Molecular Diagnostics in 2020
2.2.2 Major Players Market Distribution in 2020
2.3 Oncology Molecular Diagnostics Manufacturing Cost Structure Analysis
2.3.1 Production Process Analysis
2.3.2 Manufacturing Cost Structure of Oncology Molecular Diagnostics
2.3.3 Labor Cost of Oncology Molecular Diagnostics
2.4 Market Channel Analysis of Oncology Molecular Diagnostics
2.5 Major Down Stream Customers by Application
3 Global Oncology Molecular Diagnostics Market, by Type
3.1 Global Oncology Molecular Diagnostics Revenue and Market Share by Type (2018-2021)
3.2 Global Oncology Molecular Diagnostics Production and Market Share by Type (2018-2021)
3.3 Global Oncology Molecular Diagnostics Revenue and Growth Rate by Type (2018-2021)
3.3.1 Global Oncology Molecular Diagnostics Revenue and Growth Rate of Instruments
3.3.2 Global Oncology Molecular Diagnostics Revenue and Growth Rate of Reagents
3.4 Global Oncology Molecular Diagnostics Price Analysis by Type (2018-2021)
3.4.1 Explanation of Different Type Product Price Trends
4 Oncology Molecular Diagnostics Market, by Application
4.1 Downstream Market Overview
4.2 Global Oncology Molecular Diagnostics Consumption and Market Share by Application (2018-2021)
4.3 Global Oncology Molecular Diagnostics Consumption and Growth Rate by Application (2018-2021)
4.3.1 Global Oncology Molecular Diagnostics Consumption and Growth Rate of Breast (2018-2021)
4.3.2 Global Oncology Molecular Diagnostics Consumption and Growth Rate of Colorectal (2018-2021)
4.3.3 Global Oncology Molecular Diagnostics Consumption and Growth Rate of Prostate (2018-2021)
4.3.4 Global Oncology Molecular Diagnostics Consumption and Growth Rate of Others (2018-2021)
5 Global Oncology Molecular Diagnostics Consumption, Revenue ($) by Region (2018-2021)
5.1 Global Oncology Molecular Diagnostics Revenue and Market Share by Region (2018-2021)
5.2 Global Oncology Molecular Diagnostics Consumption and Market Share by Region (2018-2021)
5.3 Global Oncology Molecular Diagnostics Consumption, Revenue, Price and Gross Margin (2018-2021)
5.4 North America Oncology Molecular Diagnostics Consumption, Revenue, Price and Gross Margin (2018-2021)
5.4.1 North America Oncology Molecular Diagnostics Market Under COVID-19
5.4.2 North America Oncology Molecular Diagnostics SWOT Analysis
5.5 Europe Oncology Molecular Diagnostics Consumption, Revenue, Price and Gross Margin (2018-2021)
5.5.1 Europe Oncology Molecular Diagnostics Market Under COVID-19
5.5.2 Europe Oncology Molecular Diagnostics SWOT Analysis
5.6 China Oncology Molecular Diagnostics Consumption, Revenue, Price and Gross Margin (2018-2021)
5.6.1 China Oncology Molecular Diagnostics Market Under COVID-19
5.6.2 China Oncology Molecular Diagnostics SWOT Analysis
5.7 Japan Oncology Molecular Diagnostics Consumption, Revenue, Price and Gross Margin (2018-2021)
5.7.1 Japan Oncology Molecular Diagnostics Market Under COVID-19
5.7.2 Japan Oncology Molecular Diagnostics SWOT Analysis
5.8 Middle East and Africa Oncology Molecular Diagnostics Consumption, Revenue, Price and Gross Margin (2018-2021)
5.8.1 Middle East and Africa Oncology Molecular Diagnostics Market Under COVID-19
5.8.2 Middle East and Africa Oncology Molecular Diagnostics SWOT Analysis
5.9 India Oncology Molecular Diagnostics Consumption, Revenue, Price and Gross Margin (2018-2021)
5.9.1 India Oncology Molecular Diagnostics Market Under COVID-19
5.9.2 India Oncology Molecular Diagnostics SWOT Analysis
5.10 South America Oncology Molecular Diagnostics Consumption, Revenue, Price and Gross Margin (2018-2021)
5.10.1 South America Oncology Molecular Diagnostics Market Under COVID-19
5.10.2 South America Oncology Molecular Diagnostics SWOT Analysis
5.11 South Korea Oncology Molecular Diagnostics Consumption, Revenue, Price and Gross Margin (2018-2021)
5.11.1 South Korea Oncology Molecular Diagnostics Market Under COVID-19
5.11.2 South Korea Oncology Molecular Diagnostics SWOT Analysis
5.12 Southeast Asia Oncology Molecular Diagnostics Consumption, Revenue, Price and Gross Margin (2018-2021)
5.12.1 Southeast Asia Oncology Molecular Diagnostics Market Under COVID-19
5.12.2 Southeast Asia Oncology Molecular Diagnostics SWOT Analysis
6 Global Oncology Molecular Diagnostics Production by Top Regions (2018-2021)
6.1 Global Oncology Molecular Diagnostics Production by Top Regions (2018-2021)
6.2 North America Oncology Molecular Diagnostics Production and Growth Rate
6.3 Europe Oncology Molecular Diagnostics Production and Growth Rate
6.4 China Oncology Molecular Diagnostics Production and Growth Rate
6.5 Japan Oncology Molecular Diagnostics Production and Growth Rate
6.6 India Oncology Molecular Diagnostics Production and Growth Rate
7 Global Oncology Molecular Diagnostics Consumption by Regions (2018-2021)
7.1 Global Oncology Molecular Diagnostics Consumption by Regions (2018-2021)
7.2 North America Oncology Molecular Diagnostics Consumption and Growth Rate
7.3 Europe Oncology Molecular Diagnostics Consumption and Growth Rate
7.4 China Oncology Molecular Diagnostics Consumption and Growth Rate
7.5 Japan Oncology Molecular Diagnostics Consumption and Growth Rate
7.6 Middle East & Africa Oncology Molecular Diagnostics Consumption and Growth Rate
7.7 India Oncology Molecular Diagnostics Consumption and Growth Rate
7.8 South America Oncology Molecular Diagnostics Consumption and Growth Rate
7.9 South Korea Oncology Molecular Diagnostics Consumption and Growth Rate
7.10 Southeast Asia Oncology Molecular Diagnostics Consumption and Growth Rate
8 Competitive Landscape
8.1 Competitive Profile
8.2 Myriad Genetics Market Performance Analysis
8.2.1 Company Profiles
8.2.2 Oncology Molecular Diagnostics Product Profiles, Application and Specification
8.2.3 Myriad Genetics Sales, Revenue, Price, Gross Margin 2018-2021
8.2.4 Company Recent Development
8.2.5 Strategies for Company to Deal with the Impact of COVID-19
8.3 Eragen Market Performance Analysis
8.3.1 Company Profiles
8.3.2 Oncology Molecular Diagnostics Product Profiles, Application and Specification
8.3.3 Eragen Sales, Revenue, Price, Gross Margin 2018-2021
8.3.4 Company Recent Development
8.3.5 Strategies for Company to Deal with the Impact of COVID-19
8.4 Genomix Biotech Market Performance Analysis
8.4.1 Company Profiles
8.4.2 Oncology Molecular Diagnostics Product Profiles, Application and Specification
8.4.3 Genomix Biotech Sales, Revenue, Price, Gross Margin 2018-2021
8.4.4 Company Recent Development
8.4.5 Strategies for Company to Deal with the Impact of COVID-19
8.5 Nuvera Biosciences Market Performance Analysis
8.5.1 Company Profiles
8.5.2 Oncology Molecular Diagnostics Product Profiles, Application and Specification
8.5.3 Nuvera Biosciences Sales, Revenue, Price, Gross Margin 2018-2021
8.5.4 Company Recent Development
8.5.5 Strategies for Company to Deal with the Impact of COVID-19
8.6 Asuragen Market Performance Analysis
8.6.1 Company Profiles
8.6.2 Oncology Molecular Diagnostics Product Profiles, Application and Specification
8.6.3 Asuragen Sales, Revenue, Price, Gross Margin 2018-2021
8.6.4 Company Recent Development
8.6.5 Strategies for Company to Deal with the Impact of COVID-19
8.7 GeneNews Market Performance Analysis
8.7.1 Company Profiles
8.7.2 Oncology Molecular Diagnostics Product Profiles, Application and Specification
8.7.3 GeneNews Sales, Revenue, Price, Gross Margin 2018-2021
8.7.4 Company Recent Development
8.7.5 Strategies for Company to Deal with the Impact of COVID-19
8.8 NorDiag Market Performance Analysis
8.8.1 Company Profiles
8.8.2 Oncology Molecular Diagnostics Product Profiles, Application and Specification
8.8.3 NorDiag Sales, Revenue, Price, Gross Margin 2018-2021
8.8.4 Company Recent Development
8.8.5 Strategies for Company to Deal with the Impact of COVID-19
8.9 Innogenetics Market Performance Analysis
8.9.1 Company Profiles
8.9.2 Oncology Molecular Diagnostics Product Profiles, Application and Specification
8.9.3 Innogenetics Sales, Revenue, Price, Gross Margin 2018-2021
8.9.4 Company Recent Development
8.9.5 Strategies for Company to Deal with the Impact of COVID-19
8.10 Kreatech Holding Market Performance Analysis
8.10.1 Company Profiles
8.10.2 Oncology Molecular Diagnostics Product Profiles, Application and Specification
8.10.3 Kreatech Holding Sales, Revenue, Price, Gross Margin 2018-2021
8.10.4 Company Recent Development
8.10.5 Strategies for Company to Deal with the Impact of COVID-19
8.11 QIAGEN Market Performance Analysis
8.11.1 Company Profiles
8.11.2 Oncology Molecular Diagnostics Product Profiles, Application and Specification
8.11.3 QIAGEN Sales, Revenue, Price, Gross Margin 2018-2021
8.11.4 Company Recent Development
8.11.5 Strategies for Company to Deal with the Impact of COVID-19
8.12 Angsana Molecular and Diagnostics Market Performance Analysis
8.12.1 Company Profiles
8.12.2 Oncology Molecular Diagnostics Product Profiles, Application and Specification
8.12.3 Angsana Molecular and Diagnostics Sales, Revenue, Price, Gross Margin 2018-2021
8.12.4 Company Recent Development
8.12.5 Strategies for Company to Deal with the Impact of COVID-19
8.13 Beckman Coulter Market Performance Analysis
8.13.1 Company Profiles
8.13.2 Oncology Molecular Diagnostics Product Profiles, Application and Specification
8.13.3 Beckman Coulter Sales, Revenue, Price, Gross Margin 2018-2021
8.13.4 Company Recent Development
8.13.5 Strategies for Company to Deal with the Impact of COVID-19
8.14 Autogenomics Market Performance Analysis
8.14.1 Company Profiles
8.14.2 Oncology Molecular Diagnostics Product Profiles, Application and Specification
8.14.3 Autogenomics Sales, Revenue, Price, Gross Margin 2018-2021
8.14.4 Company Recent Development
8.14.5 Strategies for Company to Deal with the Impact of COVID-19
8.15 Cangen Biotechnologies Market Performance Analysis
8.15.1 Company Profiles
8.15.2 Oncology Molecular Diagnostics Product Profiles, Application and Specification
8.15.3 Cangen Biotechnologies Sales, Revenue, Price, Gross Margin 2018-2021
8.15.4 Company Recent Development
8.15.5 Strategies for Company to Deal with the Impact of COVID-19
8.16 Source MDx Market Performance Analysis
8.16.1 Company Profiles
8.16.2 Oncology Molecular Diagnostics Product Profiles, Application and Specification
8.16.3 Source MDx Sales, Revenue, Price, Gross Margin 2018-2021
8.16.4 Company Recent Development
8.16.5 Strategies for Company to Deal with the Impact of COVID-19
8.17 Epigenomics Market Performance Analysis
8.17.1 Company Profiles
8.17.2 Oncology Molecular Diagnostics Product Profiles, Application and Specification
8.17.3 Epigenomics Sales, Revenue, Price, Gross Margin 2018-2021
8.17.4 Company Recent Development
8.17.5 Strategies for Company to Deal with the Impact of COVID-19
8.18 Becton.Dickinson and Company Market Performance Analysis
8.18.1 Company Profiles
8.18.2 Oncology Molecular Diagnostics Product Profiles, Application and Specification
8.18.3 Becton.Dickinson and Company Sales, Revenue, Price, Gross Margin 2018-2021
8.18.4 Company Recent Development
8.18.5 Strategies for Company to Deal with the Impact of COVID-19
8.19 Exiqon Market Performance Analysis
8.19.1 Company Profiles
8.19.2 Oncology Molecular Diagnostics Product Profiles, Application and Specification
8.19.3 Exiqon Sales, Revenue, Price, Gross Margin 2018-2021
8.19.4 Company Recent Development
8.19.5 Strategies for Company to Deal with the Impact of COVID-19
8.20 OncoMethylome Sciences Market Performance Analysis
8.20.1 Company Profiles
8.20.2 Oncology Molecular Diagnostics Product Profiles, Application and Specification
8.20.3 OncoMethylome Sciences Sales, Revenue, Price, Gross Margin 2018-2021
8.20.4 Company Recent Development
8.20.5 Strategies for Company to Deal with the Impact of COVID-19
8.21 Hologic Market Performance Analysis
8.21.1 Company Profiles
8.21.2 Oncology Molecular Diagnostics Product Profiles, Application and Specification
8.21.3 Hologic Sales, Revenue, Price, Gross Margin 2018-2021
8.21.4 Company Recent Development
8.21.5 Strategies for Company to Deal with the Impact of COVID-19
8.22 Prediction Sciences Market Performance Analysis
8.22.1 Company Profiles
8.22.2 Oncology Molecular Diagnostics Product Profiles, Application and Specification
8.22.3 Prediction Sciences Sales, Revenue, Price, Gross Margin 2018-2021
8.22.4 Company Recent Development
8.22.5 Strategies for Company to Deal with the Impact of COVID-19
8.23 BioMerieux Market Performance Analysis
8.23.1 Company Profiles
8.23.2 Oncology Molecular Diagnostics Product Profiles, Application and Specification
8.23.3 BioMerieux Sales, Revenue, Price, Gross Margin 2018-2021
8.23.4 Company Recent Development
8.23.5 Strategies for Company to Deal with the Impact of COVID-19
8.24 EXACT Sciences Market Performance Analysis
8.24.1 Company Profiles
8.24.2 Oncology Molecular Diagnostics Product Profiles, Application and Specification
8.24.3 EXACT Sciences Sales, Revenue, Price, Gross Margin 2018-2021
8.24.4 Company Recent Development
8.24.5 Strategies for Company to Deal with the Impact of COVID-19
8.25 Predictive Biosciences Market Performance Analysis
8.25.1 Company Profiles
8.25.2 Oncology Molecular Diagnostics Product Profiles, Application and Specification
8.25.3 Predictive Biosciences Sales, Revenue, Price, Gross Margin 2018-2021
8.25.4 Company Recent Development
8.25.5 Strategies for Company to Deal with the Impact of COVID-19
8.26 Orion Genomics Market Performance Analysis
8.26.1 Company Profiles
8.26.2 Oncology Molecular Diagnostics Product Profiles, Application and Specification
8.26.3 Orion Genomics Sales, Revenue, Price, Gross Margin 2018-2021
8.26.4 Company Recent Development
8.26.5 Strategies for Company to Deal with the Impact of COVID-19
8.27 Health Discovery Market Performance Analysis
8.27.1 Company Profiles
8.27.2 Oncology Molecular Diagnostics Product Profiles, Application and Specification
8.27.3 Health Discovery Sales, Revenue, Price, Gross Margin 2018-2021
8.27.4 Company Recent Development
8.27.5 Strategies for Company to Deal with the Impact of COVID-19
8.28 Genera Biosystems Market Performance Analysis
8.28.1 Company Profiles
8.28.2 Oncology Molecular Diagnostics Product Profiles, Application and Specification
8.28.3 Genera Biosystems Sales, Revenue, Price, Gross Margin 2018-2021
8.28.4 Company Recent Development
8.28.5 Strategies for Company to Deal with the Impact of COVID-19
8.29 Intergenetics Market Performance Analysis
8.29.1 Company Profiles
8.29.2 Oncology Molecular Diagnostics Product Profiles, Application and Specification
8.29.3 Intergenetics Sales, Revenue, Price, Gross Margin 2018-2021
8.29.4 Company Recent Development
8.29.5 Strategies for Company to Deal with the Impact of COVID-19
8.30 Vermillion Market Performance Analysis
8.30.1 Company Profiles
8.30.2 Oncology Molecular Diagnostics Product Profiles, Application and Specification
8.30.3 Vermillion Sales, Revenue, Price, Gross Margin 2018-2021
8.30.4 Company Recent Development
8.30.5 Strategies for Company to Deal with the Impact of COVID-19
8.31 Abbott Diagnostics Market Performance Analysis
8.31.1 Company Profiles
8.31.2 Oncology Molecular Diagnostics Product Profiles, Application and Specification
8.31.3 Abbott Diagnostics Sales, Revenue, Price, Gross Margin 2018-2021
8.31.4 Company Recent Development
8.31.5 Strategies for Company to Deal with the Impact of COVID-19
8.32 SensiGen Market Performance Analysis
8.32.1 Company Profiles
8.32.2 Oncology Molecular Diagnostics Product Profiles, Application and Specification
8.32.3 SensiGen Sales, Revenue, Price, Gross Margin 2018-2021
8.32.4 Company Recent Development
8.32.5 Strategies for Company to Deal with the Impact of COVID-19
8.33 Agendia Market Performance Analysis
8.33.1 Company Profiles
8.33.2 Oncology Molecular Diagnostics Product Profiles, Application and Specification
8.33.3 Agendia Sales, Revenue, Price, Gross Margin 2018-2021
8.33.4 Company Recent Development
8.33.5 Strategies for Company to Deal with the Impact of COVID-19
8.34 Cepheid Market Performance Analysis
8.34.1 Company Profiles
8.34.2 Oncology Molecular Diagnostics Product Profiles, Application and Specification
8.34.3 Cepheid Sales, Revenue, Price, Gross Margin 2018-2021
8.34.4 Company Recent Development
8.34.5 Strategies for Company to Deal with the Impact of COVID-19
8.35 Genomic Health Market Performance Analysis
8.35.1 Company Profiles
8.35.2 Oncology Molecular Diagnostics Product Profiles, Application and Specification
8.35.3 Genomic Health Sales, Revenue, Price, Gross Margin 2018-2021
8.35.4 Company Recent Development
8.35.5 Strategies for Company to Deal with the Impact of COVID-19
8.36 Nanosphere Market Performance Analysis
8.36.1 Company Profiles
8.36.2 Oncology Molecular Diagnostics Product Profiles, Application and Specification
8.36.3 Nanosphere Sales, Revenue, Price, Gross Margin 2018-2021
8.36.4 Company Recent Development
8.36.5 Strategies for Company to Deal with the Impact of COVID-19
8.37 Roche Diagnostics Market Performance Analysis
8.37.1 Company Profiles
8.37.2 Oncology Molecular Diagnostics Product Profiles, Application and Specification
8.37.3 Roche Diagnostics Sales, Revenue, Price, Gross Margin 2018-2021
8.37.4 Company Recent Development
8.37.5 Strategies for Company to Deal with the Impact of COVID-19
8.38 Diagnocure Market Performance Analysis
8.38.1 Company Profiles
8.38.2 Oncology Molecular Diagnostics Product Profiles, Application and Specification
8.38.3 Diagnocure Sales, Revenue, Price, Gross Margin 2018-2021
8.38.4 Company Recent Development
8.38.5 Strategies for Company to Deal with the Impact of COVID-19
8.39 HTG Molecular Market Performance Analysis
8.39.1 Company Profiles
8.39.2 Oncology Molecular Diagnostics Product Profiles, Application and Specification
8.39.3 HTG Molecular Sales, Revenue, Price, Gross Margin 2018-2021
8.39.4 Company Recent Development
8.39.5 Strategies for Company to Deal with the Impact of COVID-19
8.40 Rosetta Genomics Market Performance Analysis
8.40.1 Company Profiles
8.40.2 Oncology Molecular Diagnostics Product Profiles, Application and Specification
8.40.3 Rosetta Genomics Sales, Revenue, Price, Gross Margin 2018-2021
8.40.4 Company Recent Development
8.40.5 Strategies for Company to Deal with the Impact of COVID-19
9 Global Oncology Molecular Diagnostics Market Analysis and Forecast by Type and Application
9.1 Global Oncology Molecular Diagnostics Market Revenue & Volume Forecast, by Type (2021-2026)
9.1.1 Instruments Market Revenue and Volume Forecast (2021-2026)
9.1.2 Reagents Market Revenue and Volume Forecast (2021-2026)
9.2 Global Oncology Molecular Diagnostics Market Revenue & Volume Forecast, by Application (2021-2026)
9.2.1 Breast Market Revenue and Volume Forecast (2021-2026)
9.2.2 Colorectal Market Revenue and Volume Forecast (2021-2026)
9.2.3 Prostate Market Revenue and Volume Forecast (2021-2026)
9.2.4 Others Market Revenue and Volume Forecast (2021-2026)
10 Oncology Molecular Diagnostics Market Supply and Demand Forecast by Region
10.1 North America Market Supply and Demand Forecast (2021-2026)
10.2 Europe Market Supply and Demand Forecast (2021-2026)
10.3 China Market Supply and Demand Forecast (2021-2026)
10.4 Japan Market Supply and Demand Forecast (2021-2026)
10.5 Middle East and Africa Market Supply and Demand Forecast (2021-2026)
10.6 India Market Supply and Demand Forecast (2021-2026)
10.7 South America Market Supply and Demand Forecast (2021-2026)
10.8 South Korea Market Supply and Demand Forecast (2021-2026)
10.9 Southeast Asia Market Supply and Demand Forecast (2021-2026)
10.10 Explanation of Market Size Trends by Region
10.11 Oncology Molecular Diagnostics Market Trends Analysis
11 New Project Feasibility Analysis
11.1 Industry Barriers and New Entrants SWOT Analysis
11.2 Analysis and Suggestions on New Project Investment
12 Expert Interview Record
13 Research Finding and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Data Source
?
